The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
Elevating CKD-aP Care: New Frontier
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Kappa-Opioid Settings: Real-World Evidence Insights
Emilio Sanchez, MD, PhD
CKD-aP: Beyond the Surface
Leonie Kraft, MD
CKD-aP Treatment Tool Kit
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Beyond GDMT: Timely Consideration of Barostim in Heart Failure
Patrick J. McCann, MD
Rajeev Mohan, MD
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
The Critical Interplay: CKD, HF, and Hyperkalemia
Integrating the Patient Voice in FSGS Management
Meghan Sise, MD
FSGS: Interpretation of Proteinuria Reduction Thresholds
Vladimir Tesar
DEARA Versus SOC in FSGS Management: Clinical Trial Insights
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Raman Sankar, MD, PhD
Scott Aaronson, MD